Showing results (51-60 of 185) with videos related to
Sort By:
Pageof 19
Current Medicinal Chemistry. Anti-Cancer Agents|August 17, 2005
Programmable DNA binding oligomers for control of transcriptionPeter B Dervan, Raymond M Doss, Michael A MarquesCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2005
Fundamental, electron transfer mechanism by pyrylium-type ions for the anticancer drugs 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA)Peter KovacicCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2005
Steroid sulfatase inhibitors: their potential in the therapy of breast cancerPeter Nussbaumer, Andreas BillichCurrent Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
Carboranylporphyrins for boron neutron capture therapy of cancerRima P Evstigneeva, Andrei V Zaitsev, Valentina N Luzgina, et al.Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives as anti-tumor agentsR Singh, R G MicetichCurrent Medicinal Chemistry. Anti-Cancer Agents|November 25, 2005
Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapyYulong L Chen, Ping-Y Law, Horace H LohCurrent Medicinal Chemistry. Anti-Cancer Agents|November 25, 2005
Lycopene: a review of its potential as an anticancer agentV Bhuvaneswari, S NaginiCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemo-therapy and radiotherapyDavid A Gewirtz, Mona S Gupta, Sujatha SundaramCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinomaShintaro Abe, Makoto OtsukiCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Targeting human telomerase by antisense oligonucleotides and ribozymesM Folini, M Pennati, N ZaffaroniPageof 19